| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
Dr. Schottenfeld is John G. Searle Professor Emeritus of Epidemiology, Professor Emeritus of Internal Medicine, University of Michigan, Ann Arbor, MI.
Dr. Beebe-Dimmer is Assistant Research Scientist, Departments of Epidemiology and Urology, University of Michigan, Ann Arbor, MI.
A causal link between chronic inflammation and carcinogenesis is explored by reviewing illustrative examples of specific cancers and causal agents and mechanisms. The causal agents or pathologic conditions include microbial agents, gastroesophageal reflux, chronic cholecystitis and cholelithiasis, inflammatory bowel disease, and specific agents that cause chronic obstructive or diffuse interstitial lung disease. The proportion of total cancer deaths attributable to infectious agents is estimated to be about 20% to 25% in developing countries and 7% to 10% in more industrialized countries. Recurrent or persistent inflammation may induce, promote, or influence susceptibility to carcinogenesis by causing DNA damage, inciting tissue reparative proliferation, and/or creating a stromal "soil" that is enriched with cytokines and growth factors. Future research on the complex cascade of cellular and humoral factors participating in the chronic inflammatory process will further understanding of the pathogenesis of various cancers and potentially provide a rationale for targeted chemopreventive interventions.
This article has been cited by other articles:
|
|
 |
|
  A. E. Prizment, A. R. Folsom, and K. E. Anderson Nonsteroidal Anti-Inflammatory Drugs and Risk for Ovarian and Endometrial Cancers in the Iowa Women's Health Study Cancer Epidemiol. Biomarkers Prev., February 1, 2010; 19(2): 435 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Van Dyke, M. L. Cote, A. S. Wenzlaff, W. Chen, J. Abrams, S. Land, C. N. Giroux, and A. G. Schwartz Cytokine and Cytokine Receptor Single-Nucleotide Polymorphisms Predict Risk for Non-Small Cell Lung Cancer among Women Cancer Epidemiol. Biomarkers Prev., June 1, 2009; 18(6): 1829 - 1840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Satia, A. Littman, C. G. Slatore, J. A. Galanko, and E. White Associations of Herbal and Specialty Supplements with Lung and Colorectal Cancer Risk in the VITamins And Lifestyle Study Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1419 - 1428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Bauer and E. A. Rondini Review Paper: The Role of Inflammation in Mouse Pulmonary Neoplasia Veterinary Pathology, May 1, 2009; 46(3): 369 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Luppi, F. Franco, B. Beghe, and L. M. Fabbri Treatment of Chronic Obstructive Pulmonary Disease and Its Comorbidities Proceedings of the ATS, December 1, 2008; 5(8): 848 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-Y. Yu, P. F. Pinsky, N. E. Caporaso, N. Chatterjee, M. Baumgarten, P. Langenberg, J. P. Furuno, Q. Lan, and E. A. Engels Lung Cancer Risk Following Detection of Pulmonary Scarring by Chest Radiography in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Arch Intern Med, November 24, 2008; 168(21): 2326 - 2332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Niebuhr, A. M. Millikan, R. Yolken, Y. Li, and N. S. Weber Results From a Hypothesis Generating Case-Control Study: Herpes Family Viruses and Schizophrenia Among Military Personnel Schizophr Bull, November 1, 2008; 34(6): 1182 - 1188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kawanishi, Y. Matsui, M. Ito, J. Watanabe, T. Takahashi, K. Nishizawa, H. Nishiyama, T. Kamoto, Y. Mikami, Y. Tanaka, et al. Secreted CXCL1 Is a Potential Mediator and Marker of the Tumor Invasion of Bladder Cancer Clin. Cancer Res., May 1, 2008; 14(9): 2579 - 2587. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Iida, K. Itoh, J. M. Maher, Y. Kumagai, R. Oyasu, Y. Mori, T. Shimazui, H. Akaza, and M. Yamamoto Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis Carcinogenesis, November 1, 2007; 28(11): 2398 - 2403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. K. Roy and J. D. Khandekar Biomarkers for the Early Detection of Cancer: An Inflammatory Concept Arch Intern Med, September 24, 2007; 167(17): 1822 - 1824. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Gungor, R. W.L. Godschalk, D. M. Pachen, F. J. Van Schooten, and A. M. Knaapen Activated neutrophils inhibit nucleotide excision repair in human pulmonary epithelial cells: role of myeloperoxidase FASEB J, August 1, 2007; 21(10): 2359 - 2367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Schottenfeld and J. Beebe-Dimmer Alleviating the Burden of Cancer: A Perspective on Advances, Challenges, and Future Directions. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2049 - 2055. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Zhang, Z. Liu, and K. E. Meier Lysophosphatidic acid as a mediator for proinflammatory agonists in a human corneal epithelial cell line Am J Physiol Cell Physiol, November 1, 2006; 291(5): C1089 - C1098. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Knaapen, N. Gungor, R. P. F. Schins, P. J. A. Borm, and F. J. Van Schooten Neutrophils and respiratory tract DNA damage and mutagenesis: a review Mutagenesis, July 1, 2006; 21(4): 225 - 236. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
